Skip to content

Imunon, Inc.

IMNN· NasdaqCore metricsCIK 749647

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -10.75%
Market cap
$4.18M
6.49M shares
Filings
1,062
$500.00K
FY 2022±0.0% FY22 yoy
-$3.75M
Q3 2026N/M FY25 yoy
-$3.45M
Q3 2026N/M FY25 yoy
-$10.28M
Q3 2026derivedN/M FY25 yoy
-$0.64
Q3 2026N/M FY25 yoy
$4.04M
Q3 2026+49.5% FY25 yoy
$4.18M
—
—
1.6×
-339.13%
—

FY2025 figures · derived

Price

$0.644483.26%$3.2056past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$500.00KFY 2022
$500.00K0FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022
PeriodEndedValueKindSource trail
FY 20222022-12-31$500,000reported
FY 20212021-12-31$500,000reported
FY 20202020-12-31$500,000reported
FY 20192019-12-31$500,000reported
FY 20182018-12-31$500,000reported
FY 20172017-12-31$500,000reported

Pharmaceutical preparations

Imunon, Inc. is the 458th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR